Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 440, 990-991 (20 April 2006) | doi:10.1038/440990a; Published online 19 April 2006
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
- More Challenges
- Powered by:
nature jobs
Director, UQ Centre for Clinical Research
- University of Queensland, Brisbane, Australia
- Brisbane, Queensland, Australia
Director of Bioinformatics
- University of the Witwatersrand, Johannesburg
- Johannesburg, South Africa
Handle with care
Abstract
China's drug market is booming, and will soon be the fifth largest in the world. But despite this potential, global companies are being advised to approach the country with caution, as Colin Macilwain reports.
On the face of it, China is a mouth-watering proposition for international drug companies. In the past five years, the value of its pharmaceutical market has doubled to US$13 billion, according to the Boston Consulting Group — and it is set to double again by 2010.
To read this story in full you will need to login or make a payment (see right).
